Minsa utiliza prueba FIT para tamizaje de detección oportuna de cáncer de colon y recto

Desde 2024 a 2025 se han realizado 340 000 tamizajes. La prueba identifica sangre oculta en heces y es altamente precisa para el descarte de esta neoplasia


3 M.
Science
ID: -7477679866645352873


Similar News expand_more


Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Education
Science
Science
Science
Science
Science
Education
Science
Science
Science
Science
Science
Science
Science
Science
Science
Education
Politics
Weather
Science
Technology
Technology
Education
Science
Education
Science
Science
Politics
Science
Science
Education
Science
Politics
Education
Science
Science
Science
Science
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down